Skip to main content
Premium Trial:

Request an Annual Quote

Avantra Partners with TGen Drug Development to Build Assays for Biomarker Workstation

Premium

By Justin Petrone

Avantra Biosciences this week said that it will work with TGen Drug Development, or TD2, to test and develop applications for its Q400 Biomarker Workstation.

Launched this week, the Q400 is an automated multiplex immunoassay system that can be used to evaluate the associations between elevated protein levels, unique patient characteristics, and drug responses. Woburn, Mass.-based Avantra also launched its Angio Qx BioChip Immunoassay, which it claims can be used to measure biomarkers that can predict how cancer patients will respond to new drug therapies.

TD2, based in Scottsdale, Ariz., assists drug-development firms in moving laboratory discoveries through the pre-clinical, clinical, and regulatory approval steps. Avantra said that TD2's pharma clients could use its platform to identify appropriate biomarkers for use with drugs in development.

The firm also hopes that the collaboration will allow it to expand its menu of assays. Avantra CEO Brian McKernan said in a statement that the partnership could "enable Avantra to expedite the release of new oncology-focused QPDx BioChip panels, and enable TD2 to couple advanced multiplex protein technologies with their innovative drug profiling platform."

Financial terms of the deal were not discussed.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.